Please sign in to follow a disease.
Allergic asthma
MONDO:0004784A asthma with a basis in a pathological type I hypersensitivity reaction.
Also known as: allergic form of asthma
49 clinical trials for this condition and its sub-types, 41 tagged with Allergic asthma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic asthma
-
Isocyanate induced asthma 0 trials
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis study tests an experimental drug called SIM0718 for people with asthma that is not well controlled by current inhalers. About 418 adults and teens aged 12 to 75 will receive either the drug or a placebo for one year. The main goal is to see if the drug reduces the number of …
Phase 3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Biosimilar switch for asthma and hives under Real-World study
Disease control Recruiting nowThis study is observing 225 adults with severe allergic asthma or chronic hives who are already doing well on the original omalizumab drug. Their doctors have decided to switch them to a biosimilar version called Omlyclo. The main goal is to see if they stay well-controlled for 1…
Sponsor: Celltrion HealthCare France • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New asthma shot aims to cut attacks in half
Disease control Recruiting nowThis study tests an experimental drug called LP-003 in 200 adults with moderate to severe allergic asthma. The goal is to see if it reduces asthma attacks and improves breathing compared to a placebo or an active drug. Participants receive injections and are monitored for about a…
Phase 2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New asthma drug shows promise in early trial
Disease control Recruiting nowThis study tests whether a new drug, FB825, can help adults with moderate-to-severe allergic asthma. About 100 participants will receive either FB825 or a placebo. The main goal is to see if FB825 reduces asthma attacks over 24 weeks.
Phase 2 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New inhaler aims to calm asthma Flare-Ups
Symptom relief Recruiting nowThis study tests an inhaled medication called ARO-RAGE in 36 adults with mild asthma that is triggered by allergens. The goal is to see if it improves small airway function after breathing in an allergen. Participants will receive either the drug or a placebo and be monitored for…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Asthma relief in a chew? plant stanols put to the test
Symptom relief Recruiting nowThis study is testing whether eating a soft chew containing plant stanols every day can reduce asthma symptoms in people with allergic asthma. Plant stanols are known to lower cholesterol, but they may also shift the immune system away from the type of response that triggers asth…
Sponsor: Maastricht University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Cat allergy treatment gets a needle upgrade: fewer shots, same hope
Symptom relief Recruiting nowThis study tests a new method for treating cat allergies called intralymphatic immunotherapy (ILIT), where allergen extracts are injected directly into a lymph node. Thirty-six adults with cat-triggered allergic rhinitis and asthma will receive 3-4 ultrasound-guided injections. T…
Phase 1/2 • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Asthma supplement trial aims to ease breathing and anxiety in kids
Symptom relief Recruiting nowThis study is testing whether a natural supplement called 5HTP can improve breathing and reduce anxiety in children aged 8-18 with mild to moderate asthma and allergies. About 20 participants will be randomly assigned to take either 5HTP or a placebo, then switch groups later. Th…
Phase 2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New allergy shot alternative could ease sneezing and itchy eyes
Symptom relief Recruiting nowThis study tests a new under-the-tongue treatment (MM09) for people with rhinitis or rhinoconjunctivitis caused by house mite allergy, with or without mild asthma. About 736 participants aged 12 to 65 will receive either MM09 or a placebo to see if it reduces allergy symptoms and…
Phase 3 • Sponsor: Inmunotek S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
400 asthma patients tracked for 5 years to uncover environmental triggers
Knowledge-focused Recruiting nowThis study follows 400 adults aged 18–60 with moderate-to-severe asthma for up to 5 years. Researchers collect blood, urine, stool, dust, saliva, and lung samples at regular visits to see how bacteria and other environmental factors affect asthma symptoms and flare-ups. The goal …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a single protein explain Asthma's many faces?
Knowledge-focused Recruiting nowThis study looks at a protein called TSLP, which is involved in airway inflammation, and its two forms (short and long) in people with different types of asthma. Researchers will measure TSLP levels in blood and nasal cells from 70 adults with asthma and compare them to healthy c…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Can a breath test or MRI spot asthma Flare-Ups before they start?
Knowledge-focused Recruiting nowThis small study in people with mild allergic asthma aims to see whether non-invasive methods like gas-enhanced MRI and exhaled breath analysis can detect lung inflammation caused by allergens. Participants will undergo both inhaled and segmental (via bronchoscopy) allergen chall…
Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
530 hay fever volunteers needed to stop thunderstorm asthma attacks
Knowledge-focused Recruiting nowThis study is looking for 530 adults with hay fever in South-Eastern Australia to help create a tool that predicts thunderstorm asthma. Participants will have allergy and lung function tests, then track their symptoms during spring for two years. The goal is to find warning signs…
Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Massive study tracks 1,000 people to unlock secrets of eczema remission
Knowledge-focused Recruiting nowThis long-term study follows 1,000 people with eczema and related allergies, plus healthy volunteers, to see what factors help the disease go into remission. Researchers will collect medical and lifestyle data to find patterns and possible biomarkers. The goal is to better unders…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Asthma study seeks to tailor rehab by type
Knowledge-focused Recruiting nowThis study looks at 60 adults aged 35-75 with allergic or eosinophilic asthma to see if their symptoms, breathing problems, and frailty levels differ. Researchers will measure lung function, breathlessness, fatigue, and quality of life. The goal is to help health professionals de…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists probe Asthma's hidden fire: allergen challenge trial launches
Knowledge-focused Recruiting nowThis study looks at how the lungs of people with asthma react when exposed to common allergens like cat hair or dust mites. Researchers will use a bronchoscope to deliver tiny amounts of allergen into the lung and then collect fluid to study which immune cells show up. The goal i…
Phase 1 • Sponsor: Benjamin Medoff • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC